Allstate Corp. (ALL) Posts Narrower than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts ALL Hot Sheet
Price: $255.26 -1.66%
EPS Growth %: -41.2%
Financial Fact:
Amortization of deferred policy acquisition costs: 1.14B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -41.2%
Financial Fact:
Amortization of deferred policy acquisition costs: 1.14B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Allstate Corp. (NYSE: ALL) reported Q2 EPS of ($1.19), $0.37 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $6.46 billion versus the consensus estimate of $6.58 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- What is the Property Lab at Allstate Claims University? How Allstate trains property claim adjusters to help homeowners recover after damage
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
